ANTİDEPRESAN İLAÇLAR VE GENOTOKSİSİTE

Yıl 2016, Cilt: 9 Sayı: 1, 17 - 28, 07.05.2016

Deniz Yüzbaşıoğlu , Ece Avuloğlu Yılmaz , Fatma Ünal

Öz

Depresyon sinirlilik, uykusuzluk, yorgunluk, ajitasyon, psikomotor değişiklikler, suçluluk, kendine değer vermeme ile karakterize kompleks bir hastalıktır. Bu hastalığın tedavisinde en sık kullanılan yöntem antidepresan kullanımıdır.  Antidepresanlar çok sayıda hastada uzun süreli kullanılan ilaçlardır ve literatürde bunların genotoksik etkilerini rapor eden çeşitli çalışmalar vardır. İlaçlar piyasaya sürülmeden önce genotoksisite testlerini de içeren bazı testlerin yapılması gereklidir. Genotoksisite çalışmaları bir kimyasalın DNA hasarına neden olup olmadığını belirler. Bu DNA hasarı tek ve çift zincir kırıkları, eksizyon onarım kaybı, çapraz bağlar, alkali labil bölgeler, nokta mutasyonları ve yapısal ve sayısal kromozomal anomaliler şeklinde olabilir. Günümüzde, antidepresan kullanımının hızla artması sonucunda bu ilaçların genetik yapıda olumsuz etkileri olup olmadığının tespit edilmesi son derece önem kazanmıştır. Bakterilerde, in vivo ve in vitro memeli hücrelerinde, bitkilerde veya Drosophila’da çeşitli test sistemleri herhangi bir kimyasal ajanın indüklediği genetik hasarı değerlendirmek için kullanılmaktadır. Bu çalışmada, farklı test sistemlerinde antidepresanların daha önce yayınlanmış genotoksisite test sonuçları derlenmiştir.

 

Anahtar Kelimeler

Antidepresan ilaçlar, genotoksisite

Kaynakça

• A. Azqueta, Y. Lorenzo, A.R. Collins, “In vitro comet assay for DNA repair: a warning concerning application to cultured cells”, Mutagenesis, 24(4): 379-381 (2009).
• A. Balbi, G. Muscettola, N. Staiano, G. Martire, F. De Lorenzo, “Psychotropic drugs: evaluation of mutagenic effect”, Pharmacological Research Communications, 12: 423–431 (1980).
• A. Collins, G. Koppen, V. Valdiglesias, M. Dusinska, M. Kruszewski, P. Møller, E. Rojas, A. Dhawan, I. Benzie, E. Coskun, M. Moretti, G. Speit, S. Bonassi, “The comet assay as a tool for human biomonitoring studies: The ComNet Project”, Mutation Research, 759: 27–39 (2014).
• A. Frolich, F.E. Würgler, “Drosophila wing-spot test: improved detectability of genotoxicity of polycyclic aromatic hydrocarbons”, Mutation Research, 234: 71-80 (1990).
• A. Montoro, J.M. Soriano, J.F. Barquinero, M. Almonacid, A. Montoro, G. Verdu V. Sahuquillo, J.I. Villaescusa, N. Sebastia, “Assessment in vitro of cytogenetic and genotoxic effects of propolis on human lymphocytes”, Food and Chemical Toxicology, 50: 216-221 (2012).
• A. Nersesyan, M. Kundi, M. Fenech, C. Bolognesi, M. Misik, G. Wultsch, M. Hartmann, S. Knasmueller, “Micronucleus assay with urine derived cells (UDC): A review of its application in human studies investigating genotoxin exposure and bladder cancer risk”, Mutation Research, http://dx.doi.org/ 10.1016/j.mrrev.2014.04.004 (2014).
• A. Santoro, G. Bianco, P. Picerno, R.P. Aquino, G. Autore, S. Marzocco, P. Gazzerro, M.B. Lioi, M. Bifulco, “Verminoside and verbascoside-induced genotoxicity on human lymphocytes: Involvement of PARP-1 and p53 proteins”, Toxicology Letters, 178(2): 71-76 (2008).
• A. Santovito, P. Cervella, M. Delpero, “Increased frequency of chromosomal aberrationsand sister chromatid exchanges in peripheral lymphocytes of radiology technicians chronically exposed to low levels of ionizing radiations”, Environmental Toxicology and Pharmacology, 37: 396-403 (2014).
• A. Steingart, M. Cotterchio, N. Kreiger, M. Sloan, “Antidepressant medication use and breast cancer risk: a case-control study”, International Journal of Epidemiology, 32: 961–966 (2003).
• A.R. Collins, “Measuring oxidative damage to DNA and its repair with the comet assay”, Biochimica et Biophysica Acta, 1840: 794–800 (2014).
• B. N. Ames, J. McCann, E. Yamasaki, “Methods for Detecting Carcinogens and Mutagens with the Salmonella/Mammalian-Microsome Mutagenicity Test”, Mutat. Res. 31: 347-364 (1975).
• B. Özyüksel, B. Uluğ, “Depresyon tanısı alan hastalarda kalıntı belirtilerin yetiyitimi ile İlişkisi: 3 Aylık İzlem Çalışması”, Türk Psikiyatri Dergisi, 18(4): 323-332. (2007).
• B. Uluğ, A. Ertuğrul, A. Göğüş, E. Kabakçı, “Yetiyitimi Değerlendirme çizelgesinin (WHO-DAS-II) şizofreni hastalarında geçerlilik ve güvenirliği”, Türk Psikiyatri Dergisi, 12(2): 121-130, (2001).
• B.T. Ji, D.T. Silverman, P.A. Stewart, A. Blair, G.M. Swanson, D. Baris, R.S. Greenberg, R.B. Hayes, L.M. Brown, K.D. Lillemoe, J.B. Schoenberg, L.M. Pottern, A.G. Schwartz, R.N. Hoover, “Occupational exposure to pesticides and pancreatic cancer” American Journal of Industrial Medicine, 39 (1): 92-99 (2001).
• C. Fei, J. Zhang, Y. Lin, X. Wang, K. Zhang, L. Zhang, W. Zheng, M. Wang, T. Li, S. Xiao, F. Xue, C. Wang, “Safety evaluation of a triazine compound nitromezuril by assessing bacterial reverse mutation, sperm abnormalities, micronucleus and chromosomal aberration”, Regulatory Toxicology and Pharmacology, 71: 585–589 (2015).
• C. Ginzkey, G. Steussloff, C. Koehler, M. Burghartz, A. Scherzed, S. Hackenberg, R. Hagen, N.H. Kleinsasser, “Nicotine derived genotoxic effects in human primary parotid gland cells as assessed in vitro by comet assay, cytokinesis-block micronucleus test and chromosome aberrations test”, Toxicology in vitro, 28: 838–846 (2014).
• C. Hoelzl, S. Knasmüller, M. Misic, A. Collins, M. Dusinska, A. Nersesyan, “Use of single cell gel electrophoresis assays for the detection of DNA-protective effects of dietary factors in humans: Recent results and trends”, Mutation Research, 681: 68-79 (2009).
• C. Richard, M.D. Shelton, “Classification of antidepressants and their clinical implications”, Primary Care Companion Journal of Clinical Psychiatry, 5[suppl 7]: 27–32 (2003).
• D. Battal, A. Aktas, M.A. Sungur, E. Kadioglu, E. Derici Eker, N. Ozlen Sahin, S. Saygi, “In Vivo Genotoxicity Assessment of Sertraline by Using Alkaline Comet Assay and the Cytokinesis-Block Micronucleus Assay”, Basic & Clinical Pharmacology & Toxicology, 113(5): 339-346 (2013).
• D. Cavallo, C.L. Ursini, B. Perniconi, A. Francesco, M. Giglio, F.M. Rubino, A. Marinaccio, S. Iavicoli, “Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees”, Mutation Research, 587: 45-51 (2005).
• D. Yüzbaşıoğlu, F. Ünal, S. Yılmaz, H. Aksoy, M. Çelik, “Genotoxicity testing of fluconazole in vivo and in vitro”, Mutation Research, 649: 155-160 (2008).
• D. Yüzbaşıoğlu, F. Ünal, F. Koç, S. Oztemel, H. Aksoy, S. Mamur, F. Demirtaş Korkmaz, Genotoxicity assessment of vaccine adjuvant squalene”, Food and Chemical Toxicology, 56:240-246 (2013).
• D.G. McArt, G. McKerr, K. Saetzler, C.V. Howard, C.N. Downes, G.R. Wasson, “Comet sensitivity in assessing DNA damage and repair in different cell cycle stages”, Mutagenesis, 25(3): 299-303 (2010).
• E. Avuloğlu, “Antidepresan ilaç etken maddeleri olan Trazodone ve Milnacipran’ın insan periferal lenfositlerinde genotoksik etkilerinin incelenmesi”, Yüksek Lisans Tezi, Gazi Üniversitesi, Fen Bilimleri Enstitüsü, Ankara (2012).
• E. Cervantes-Ríos, R. Ortiz-Muniz, A.L. Martínez-Hernández, L. Cabrera-Rojo, J. Graniel-Guerrero, L. Rodríguez-Cruz, “Malnutrition and infection influence the peripheral blood reticulocyte micronuclei frequency in children”, Mutation Research, 731: 68-74 (2012).
• E. Madrigal-Bujaidar, Y.C. Garcia, I. Alvarez-Gonzales, “Chromosomal aberrations induced by imipramine and desipramine in mouse”, Human and Experimental Toxicology, 29(4): 297-302 (2010).
• E. Zeiger, “Genetic Toxicology Testing”, Chapel Hill, NC, USA, 139-158 (2010).
• E.C. Friedberg, G.C. Walker, W. Siede, “DNA Repair and Mutagenesis”, American Society for Microbiology (ASM) Press, Washington DC, 32–33, (1995).
• G. Bozkurt, E. Abay, İ. Ateş, G. Karaboğaz, M. Türe, F.O. Savran, S. Palandüz, K. Temocin, Ç. Algüneş, “Clastogenicity of selective serotonin-reuptake inhibitors”, Mutation Research, 558: 137-144 (2004).
• G. Brambilla, F. Mattioli, A. Martelli, “Genotoxic and carcinogenic effects of antipsychotics and antidepressants”, Toxicology, 261: 77-88 (2009).
• G. Brambilla, M. Cavanna, P. Faggin, A. Pino, L. Robbiano, C. Bennicelli, P. Zanacchi, A. Camoirano, S. De Flora, “Genotoxic activity of five antidepressant hydrazines in a battery of in vivo and in vitro short-term tests”, J. Toxicol. Environ. Health, 9: 287–303 (1982b).
• G. Brambilla, M. Cavanna, S. De Flora, “Genotoxic effects of drugs: experimental findings concerning some chemical families of therapeutic relevance”, Chemical Carcinogenesis, Nicolini, C., Plenum Press, New York, 193–221, (1982a).
• G.H. Tarhan, “Antidepresan olarak kullanılan prozac ve paxil ilaçlarının insan lenfosit kültüründeki genotoksik etkileri”, Yüksek Lisans Tezi, Gazi Üniversitesi Fen Bilimleri Enstitüsü, Ankara, (2006).
• G.J.S. Jenkins, S.H. Doak, G.E. Johnson, E. Quick, E.M. Waters, J.M. Parry, “Do dose response thresholds exist for genotoxic alkylating agents?”, Mutagenesis, 20 (6): 389–398 (2005).
• G.L. Poletta, A. Larriera, E. Kleinsorge, M.D. Mudry, “Caiman latirostris (broad-snouted caiman) as a sentinel organism for genotoxic monitoring: basal values determination of micronucleus and comet assay”, Mutation Research, 650(2): 202-209 (2008).
• H.A.S. Alzahrani, “Sister chromatid exchanges and sperm abnormalities produced by antidepressant drug fluoxetine in mouse treated in vivo”, European Review for Medical and Pharmacological Sciences, 16: 2154-2161(2012).
• H.F.P. Joosten, F.A.A. Van Acker, D.J. Van den Dobbelsteen, G.J.M.J. Horbach, E.I. Krajnc, “Genotoxicity of hormonal steroids”, Toxicology Letters, 151: 113-134 (2004).
• H.J. Möller, I. Bitter, J. Bobes, K. Fountoulakis, C. Höschl, S. Kasper, “Position statement of the European Psychiatric Association (EPA) on the value of antidepressants in the treatment of unipolar depression”, European Psychiatry, 27: 114-128 (2012).
• H.M. Roshdy, A.A.Fyiad, “Cytogenetic and Biochemical Effects of Antidepression Drug (Wellbutrin) on Male Mice”, New York Science Journal, 3(6): 121-126 (2010).
• http://www.fda.gov.cder.
• http://www.toxnet.nlm.nih.gov/.
• I. Crooks, D.M. Dillon, J.K. Scott, M. Ballantyne, C. Meredith, “The effect of long term storage on tobacco smoke particulate matter in in vitro genotoxicity and cytotoxicity assays”, Regulatory Toxicology and Pharmacology, 65: 196-200 (2013).
• I. Huerta, M. Barasoain, M. Télez, M. Longa, J, Muga, G. Barrenetxea, E. Ortiz-Lastra, J. González, B. Criado, I. Arrieta, “Genotoxic evaluation of five Angiotesin II receptor blockers: In vivo and in vitro micronucleus assay”, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 767: 1-7 (2014).
• I. Valentin-Severin, V. Thybaud, A. M. L. Bon, J.C. Lhuguenot, M.C. Chagnon, “The autoradiographic test for unscheduled DNA synthesis: a sensitive assay for the detection of DNA repair in the HepG2 cell line”, Mutation Research, 559: 211–217 (2004).
• J. Clements, “The Mouse Lymphoma Assay”, Mutation Research, 455: 97–110 (2000).
• J.D. Tucker, A. Auletta, M.C. Cimino, K.L. Dearfield, D. Jacobson-Kram, R.R. Tice, A.V. Carrano, “Sister-chromatid exchange: second report the Gene-Tox Program”, Mutation Research, 297: 101–180 (1993).
• J.M. Parry, M. Kirsch-Volders, “Special issue on in vitro MN trial”, Mutation Research, 702: 132-134 (2010).
• K. McPherson, “Commentary: Antidepressants and breast cancer risk”, International Journal of Epidemiology, 32: 966–967 (2003).
• L. Hagmar, S. Bonassi, U. Stromberg, A. Brogger, L.E. Knudsen, H. Norppa, C. Reuterwall, “Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH)”, Cancer Research, 58 (18): 4117-4121(1998).
• M. Çetin, C. Açıkel, “Meta-analizler ışığında: bütün antidepresanlar aynı mıdır?”, Klinik Psikofarmakoloji Bülteni, 19: 87-92 (2009).
• M. Fenech, “Cytokinesis-block micronucleus cytome assay”, Nature Protocols, 2(5): 1084-1104 (2007).
• M. Fenech, “The in vitro micronucleus technique”, Mutation Research, 455 (1-2): 81-95 (2000).
• M. Fenech, W.P. Chang, M. Kirsch-Volders, N. Holland, S. Bonassi, E. Zeiger, “Human Micronucleus project. HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures”, Mutation Research, 534(1-2): 65-75 (2003).
• M. Kumari, A. Mukherjee, A. Chandrasekaran, “Genotoxicity of silver nanoparticles in Allium cepa” Science of the Total Environment, 407: 5243-5246 (2009).
• M. Terradas, M. Martin, L. Tusell, A. Genesca, “Genetic activites in micronuclei: Is the DNA entrapped in micronuclei lost for the cell”, Mutation Research, 705: 60-67 (2010).
• M.M. Moore, M. Honma, J. Clements, G. Bolcsfoldi, M. Cifone, R. Delongchamp, M. Fellows, B. Gollapudi, P. Jenkinson, P. Kirby, S. Kirchner, W. Muster, B. Myhr, M. O’Donovan, J. Oliver, T. Omoril, M.C. Ouldelhkim, K. Panti, R. Preston, C. Riach, R. San, L. F. Stankowski, A. Thakur, S. Wakuri, I. Yoshimura, “Mouse Lymphoma Thymidine Kinase Gene Mutation Assay: International Workshop on Genotoxicity Tests Workgroup Report—Plymouth, UK 2002”, Mutation Research, 540: 127–140 (2003).
• M.O. Ali, O.A.S. El-Deen, O.M. El-Menshay, S. Bakery, “Genotoxic effects of fluoxetine on the chromosomes of bone marrow cells of pregnant mice”, The International Association of Forensic Toxicologists, August 26-30 (2001).
• M.S. Hassanane, N. Hafiz, W. Radwan, A.A. El-Ghor, “Genotoxic evaluation for the tricyclic antidepressant drug, amitriptyline”, Drug and Chemical Toxicology, 35(4): 450-455 (2012).
• M.S. Hassanane, N. Hafiz, W. Radwan, A.A. El-Ghor, “Genotoxic evaluation for the tricyclic antidepressant drug, amitriptyline”, Drug and Chemical Toxicology, 1-6 (2012).
• N. Kumar, A. Yadav, S. Gulati, Kanupriya, N. Aggarwal, R. Gupta, “Antigenotoxic potential of curcumin and carvacrol against malathion-induced DNA damage in cultured human peripheral blood and its relation to GSTM1 and GSTT1 polymorphism”, Biomarkers and Genomic Medicine, http://dx.doi.org/10.1016/j.bgm.2015.02.002, 1-7 (2015).
• N. Sebastià, D. Hervás, M. Almonacid, J.I. Villaescusa, J.M. Soriano, V. Sahuquillo, V. Esteban, J.F. Barquinero, G. Verdú, J. Cervera, E. Such, A. Montoro, “Sister chromatid exchange, (SCE), High-Frequency Cells (HFCs) and SCE distribution patterns in peripheral blood lymphocytes of Spanish adult smokers compared to non-smokers”, Food and Chemical Toxicology, 66: 107–112 (2014).
• N. Van Schaik, U. Graf, “Genotoxicity evaluation of five tricyclic antidepressants in the wing somaticmutation and recombination test in Drosophila melanogaster”, Mutation Research, 260: 99–104 (1991).
• N. Zengin, D. Yüzbaşıoğlu, F. Ünal, S. Yılmaz, H. Aksoy, “The evaluation of the genotoxicity of two food preservatives: sodium benzoate and potassium benzoate”, Food and Chemical Toxicology, 49: 763–769 (2011).
• N.P. Singh, M.T. McCoy, R.R. Tice, E.L. Schneider, “A simple technique for quantification of low levels of DNA damage in individual cells”, Experimental Cell Research,175: 184–191 (1988).
• OECD, "Genetic Toxicology: Rodent Dominant Lethal Test", 478 (1984).
• Organization for Economic Co-operation and Development (OECD), “OECD Guidelines for the Testing of Chemicals”, Health Effects, 4: 471–486 (2008).
• Ö. Tunçer, “Depresyon ve somatizasyon”, Depresyon, Somatizasyon ve Psikiyatrik Aciller Sempozyumu, 47-52 (1999).
• P. Pereira, J. Gianesini, C.S. Barbosa, G.F. Cassol, R.G.V. Borowski, V.F.S. Kahl, S.E. Cappelari, J.N. Picada, “Neurobehavioral and genotoxic parameters of duloxetine in mice using the inhibitory avoidance task and comet assay as experimental models”, Pharmacological Research, 59: 57-61 (2009).
• P.R. Perez, E. Madrigal-Bujaidar, C.S. Reyes, G.J. Perez, M.O. Velasco, D. Molina, “Sister chromatid exchanges produces by imipramine and desipramine in mouse bone marrow cells treated in vivo”, Toxicology Letters, 132: 123-129 (2002).
• P.S. Chowdary, M.S. Rao, “Cytogenetic effects of amitriptyline hydrochloride in somatic and germ cells of mice”, Toxicology Letters, 39(2-3): 199-204 (1987).
• Physicians’ Desk Reference, 59th ed, Thomson PDR, Montvale, NJ, USA, (2005).
• R. Chandirasekar, B.L. Kumar, K. Sasikala, R. Jayakumar, K. Suresh, R. Venkatesan, R. Jacob, E.K. Krishnapriya, H. Kavitha, G.K. Ganeshda, Assessment of genotoxic and molecular mechanisms of cancer risk insmoking and smokeless tobacco users, Mutation Research, 767 (2014) 21–27.
• R. Gadassi, N. Mor, “Confusing acceptance and mere politeness: Depression and sensitivity to Duchenne smiles”, J. Behav. Ther. & Exp. Psychiat, 50: 8-14 (2016).
• R. Mateuca, N. Lombaert, P.V. Aka, I. Decordier, M. Kirsch-Volders, “Chromosomal changes: induction, detection methods and applicability in human biomonitoring”, Biochimie, 88 (11): 1515–1531 (2006).
• R. Sarıkaya, “Sodyum nitrit, sodyum nitrat, potasyum nitrit ve potasyum nitrat’ın genotoksik etkisinin somatik mutasyon ve rekombinasyon testi ile araştırılması”, Doktora Tezi, Gazi Üniversitesi Fen Bilimleri Enstitüsü, Ankara, 1-110 (2005).
• R.A. El-Zein, S.Z. Abdel-Rahmanb, M.J. Hayb, M.S. Lopeza, M.L. Bondya, D.L. Morrisb, M.S. Legatorb, “Cytogenetic effects in children treated with methylphenidate”, Cancer Letters, 230: 284–291 (2005).
• R.D. Snyder, D. Ewing, L.B. Hendry, “DNA intercalative potential of marketed drugs testing positive in in vitro cytogenetic assays”, Mutation Research, 609: 47–59 (2006).
• R.J. Preston, J.A. Skare, M.J. Aardema, “A review of biomonitoring studies measuring genotoxicity in humans exposed to hair dyes”, Mutagenesis, 25(1): 17-23 (2010).
• R.P. Araldi, T.C.D. Melo, T.B. Mendes, P.L.D. Sa´ Ju´nior, B.H.N. Nozima, E.T. Ito, R.F.D. Carvalho, E.B.D. Souza, R.D.C. Stocco, “Using the comet and micronucleus assays for genotoxicity studies: A review”, Biomedicine & Pharmacotherapy, 72: 74–82 (2015).
• S. Bonassi, A. Znaor, M. Ceppi, C. Lando, W.P. Chang, N. Holland, M. Kirsch-Volders, E. Zeiger, S. Ban, L. Barale, M.P. Bigatti, C. Bolognesi, A. Cebulska-Wasilewska, E. Fabianova, A. Fucic, L. Hagmar, G. Joksic, A. Martelli, L. Migliore, E. Mirkova, M.R. Scarfi, A. Zijno, H. Norppa, M. Fenech, “An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans”, Carcinogenesis, 28: 625–631 (2007).
• S. Garry, F. Nesslany, E. Aliouat, J.M. Haguenoer, D. Marzin, “Assessment of genotoxic effect of benzo[a]pyrene in endotracheally treated rat using the comet assay”, Mutation Research, 534(1-2): 33-43 (2003).
• S. Green, A. Auletta, J. Fabricant, R. Kapp, M. Marrandhar, C. Shen, J. Springer, B. Whitefield, “Current status of bioassays in genetic toxicology—the dominant lethal assay. A report of the U.S. Environmental Protection Agency Gene-Tox Program”, Mutation Research, 154: 49–67 (1985).
• S. Jyoti, Y.H. Siddique, S. Khan, F. Naz, R.F. Ali, “Effect on micronucleus frequency and DNA damage in buccal epithelial cells of various factors among pan masala and gutkha chewers”, Oral Science International, 12 (2015) 9–14.
• S. Örsel, “Depresyonda tedavi: Genel ilkeler ve kullanılan antidepresan ilaçlar”, Klinik Psikiyatri, Ek 4: 17-24 (2004).
• S. Shaheen, K.P. Rao, M.S. Rao, “Effect of nitroxazepine on bone marrow cells of mice”, Toxicology Letters, 44(1-2): 215-217 (1988).
• S. Sukumaran, A. Grant, “Differantial responses ok sexual and asexual Artemia to genotoxicity by a reference mutagen: Is the comet assay a reliable predictor of population level responses?”, Ecotoxicology and Environmental Safety, 91: 110-116 (2013).
• S.B. Dorn, G.H. Degen, T. Müller, D. Bonacker, H.F. Joosten, J. Van der Louw, F.A.A. Van Acker, H.M. Bolt, “Proposed criteria for specific and non-specific chromosomal genotoxicity based on hydrophobic interactions”, Mutation Research, 628: 67-75 (2007).
• S.H. Doak, Y. Liu, C. Chen, “Genotoxicity and cancer, Adverse Effects of Engineered Nanomaterials”, 14: 243-261 (2012).
• S.H. Doak, Y. Liu, C. Chen, Genotoxicity and cancer, in: B. Fadeel, A. Pietroiusti, A.A. Shvedova (Eds.), Adverse Effects of Engineered Nanomaterials, Academic Press, USA, 243-261 (2012).
• S.P. Bhatia, V.T. Politano, A.M. Api, “Evaluation of genotoxicity of nitrile fragrance ingredients using in vitro and in vivo assays”, Food and Chemical Toxicology, 59: 784-792 (2013).
• T. Beg, Y.H. Siddique, G. Ara, M. Gupta, J. Afzal, “Protective action of EGCG against anticancer drugs MMS and CP”, The Internet Journal of Pharmacology, 6(2): 1-7 (2009).
• T. Shibuya, K. Morimoto, “A review of the genotoxicity of 1-ethyl-1-nitrosourea”, Mutation Research, 297: 3–38 (1993).
• T.B. Kryston, A.B. Georgiev, P. Pissis, A.G. Georgakilas, “Role of oxidative stress and DNA damage in human carcinogenesis”, Mutation Research, 711: 193-201 (2011).
• Y. Soysal, F.İ. Şahin, S. Menevşe, “İnsan lenfosit hücre kültüründe melatonin ve b-karotenin mitomisin C ile indüklenmiş kardeş kromatid değişimi sıklığı üzerine in vitro etkileri”, Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi, 15(3): 23-29 (2008).
• Y.H. Cho, Y.J. Kim, Y.S. An, H.D. Woo, S.Y. Choi, C.M. Kang, H.W. Chung, “Micronucleus-centromere assay and DNA repair gene polymorphism in lymphocytes of industrial radiographers”, Mutation Research, 680: 17-24 (2009).
• Z. Kotan, A. Sarandöl, S.S. Eker, C. Akkaya, “Depresyon, nöroplastisite ve nörotrofik faktörler”, Psikiyatride Güncel Yaklaşımlar, 1: 22-35 (2009).
• Z. Zemanova, K. Michalova, H. Buryova, J. Brezinova, K. Kostylkova, D. Bystricka, M. Novakova, I. Sarova, S. Izakova, L. Lizcova, S. Ransdorfova, Z. Krejcik, M.D. Merkerova, A. Dohnalova, M. Siskova, A. Jonasova, R. Neuwirtova, J. Cermak, “Involvement of deleted chromosome 5 in complex chromosomalaberrations in newly diagnosed myelodysplastic syndromes (MDS) iscorrelated with extremely adverse prognosis”, Leukemia Research, 38: 537–544 (2014).